Enhancer of zeste homolog 2 (EZH2), a subunit of the polycomb repressive complex 2, contributes to S-adenosylhomocysteine inhibition-aggravated DKD in mice through EZH2/EGR1/TXNIP/NLRP3 signaling pathway (23). Here, EGR1 is linked to diabetic kidney disease.